A Study Evaluating The Safety And Efficacy Of Tolvaptan In The Treatment Of Patients With Refractory Fluid Retention After Cardiac Surgery And Predictors For Its Responders.
Phase of Trial: Phase IV
Latest Information Update: 31 Dec 2016
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Cardiac oedema
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 31 Dec 2016 New trial record
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association.